Nuffield Department of Medicine, John Radcliffe Hospital, University of Oxford, Oxford, UK.
National Institute of Health Research Oxford Biomedical Research Centre, John Radcliffe Hospital, Oxford, UK.
J Comput Chem. 2022 Oct 5;43(26):1771-1782. doi: 10.1002/jcc.26979. Epub 2022 Aug 25.
Drug resistant Mycobacterium tuberculosis, which mostly results from single nucleotide polymorphisms in antibiotic target genes, poses a major threat to tuberculosis treatment outcomes. Relative binding free energy (RBFE) calculations can rapidly predict the effects of mutations, but this approach has not been tested on large, complex proteins. We use RBFE calculations to predict the effects of M. tuberculosis RNA polymerase and DNA gyrase mutations on rifampicin and moxifloxacin susceptibility respectively. These mutations encompass a range of amino acid substitutions with known effects and include large steric perturbations and charged moieties. We find that moderate numbers (n = 3-15) of short RBFE calculations can predict resistance in cases where the mutation results in a large change in the binding free energy. We show that the method lacks discrimination in cases with either a small change in energy or that involve charged amino acids, and we investigate how these calculation errors may be decreased.
耐药结核分枝杆菌主要是由于抗生素靶基因中的单核苷酸多态性引起的,对结核病治疗结果构成重大威胁。相对结合自由能(RBFE)计算可以快速预测突变的影响,但这种方法尚未在大型复杂蛋白质上进行过测试。我们使用 RBFE 计算来预测结核分枝杆菌 RNA 聚合酶和 DNA 回旋酶突变对利福平(rifampicin)和莫西沙星(moxifloxacin)敏感性的影响。这些突变包括一系列具有已知影响的氨基酸取代,包括大的空间位阻和带电部分。我们发现,在突变导致结合自由能发生较大变化的情况下,中等数量(n=3-15)的短 RBFE 计算可以预测耐药性。我们表明,该方法在能量变化较小或涉及带电氨基酸的情况下缺乏区分能力,我们还研究了如何减少这些计算误差。